Globally, cervical cancer claims the lives of more than 340,000 women annually, ranking as the fourth most frequently observed cancer in women.
For this reason, we are thrilled to announce our strategic collaboration with BD to revolutionize cervical cancer diagnostics.
Built from the ground up using state-of-the-art AI, unbeatable user experience, security, dependability, and scalability.
Techcyte creates powerful machine learning solutions for cellular and liquid based mediums that are built on a framework of competencies that allow us to augment the work of labs and lab professionals, and to advance the field of digital diagnostics.
All meaningful advancements in tech and healthcare are imagined and built by smart, hard-working people. Find a home for your talent at Techcyte.
